Shun-Fu Chang

Title: Shun-Fu Chang: Innovator in Targeted Drug Delivery Systems

Introduction

Shun-Fu Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of targeted drug delivery systems, focusing on innovative solutions for cancer treatment. With a total of 2 patents, his work is paving the way for advancements in personalized medicine.

Latest Patents

Chang's latest patents include the "Targeted prodrug cytosine deaminase fusion carrier and application thereof." This invention provides a targeted prodrug enzyme fusion carrier that effectively identifies and binds to tumor cells and tumor-induced angiogenesis. The carrier also features a theranostic system that utilizes in vivo nuclear medicine for the clinical diagnosis and treatment of individual patients with tumors. Another notable patent is the "Dual targeting drug carrier and application thereof." This dual targeting drug carrier comprises a first and a second targeting molecule, which can bind to specific receptors, proteins, or glycoproteins to recognize specific tumor cells, tissues, or organs. These drug carriers are further conjugated with imaging agents, radioactive molecules, or nanoparticles to form a conjugate.

Career Highlights

Shun-Fu Chang is affiliated with National Yang Ming Chiao Tung University, where he continues to advance his research in drug delivery systems. His work is instrumental in developing innovative therapies that enhance the efficacy of cancer treatments.

Collaborations

Chang collaborates with esteemed colleagues, including Hsin-Ell Wang and Jia-Je Li, to further his research and development efforts in the field of targeted therapies.

Conclusion

Shun-Fu Chang's innovative work in targeted drug delivery systems exemplifies the potential of modern medicine to provide personalized treatment options for cancer patients. His contributions are vital to the ongoing evolution of therapeutic strategies in oncology.